Upgrade to SI Premium - Free Trial

Curis, Inc. (CRIS) Misses Q3 EPS by 1c; Updates on CUDC-427 Phase 1

November 6, 2013 6:17 AM
Curis, Inc. (NASDAQ: CRIS) reported Q3 EPS of ($0.02), $0.01 worse than the analyst estimate of ($0.01). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings FDA Hot Corp. News Management Comments

Next Articles